1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Epiomic Epidemiology Series: Addison’s Disease Forecast in 10 Major Markets 2016-2026

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Addison’s Disease in 10 Major Markets

Addison's disease (AD) is a chronic and rare endocrinal disorder, caused by destruction of the adrenal cortex which leads to the reduced production of glucocorticoids, mineralocorticoids and adrenal androgens. Chronic adrenal insufficiency and hypersecretion of ACTH is representative of the basic clinical signs and symptoms. AD can be part of the autoimmune polyglandular syndrome (PAS) (type 1 and 2), or it may present as an isolated disorder.

This report provides the current prevalent population for Addison’s disease across 10 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, and Poland) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Addison’s have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Addison’s disease include:

• Autoimmune Thyroiditis (AT)
• Type 1 diabetes (T1D)
• Anaemia
• Vitiligo
• Chronic Fatigue
• Premature Ovarian Failure

Hypopigmentation

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

• Able to quantify patient populations in global Addison’s disease’s market to target the development of future products, pricing strategies and launch plans.
• Gain further insight into the prevalence of the subdivided types of Addison’s disease and identify patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Provide a level of understanding on the impact from specific co-morbid conditions on Addison’s disease’s prevalent population.
• Identify sub-populations within Addison’s disease which require treatment.
• Gain an understanding of the specific markets that have the largest number of Addison’s disease patients.

Table Of Contents

Epiomic Epidemiology Series: Addison’s Disease Forecast in 10 Major Markets 2016-2026
Table of Contents
- List of Tables and Figures
- Introduction
- Cause of the Disease
- Risk Factors and Prevention
- Diagnosis of the Disease
- Variation by Geography/Ethnicity
- Disease Prognosis and Clinical Course
- Key Co-morbid Conditions/ Features Associated with the Disease
- Methodology for Quantification of Patient Numbers
- Top-Line Prevalence for Addison's Disease
- Main Complications and Features of Addison's Disease Patients
o Classification of Addison's Disease
o Number of concomitant conditions in Addison's Disease
o Co-morbidities within Addison's disease
- Abbreviations used in the Report
- Other Black Swan Analysis Publications
- Black Swan Analysis Online Patient-Based Databases
- Patient-Based Offering
- Online Pricing Data and Platforms
- References
- Appendix


List of Tables and Figures

- Prevalence of Addison's, total (000s)
- Prevalence of Addison's, males (000s)
- Prevalence of Addison's, females (000s)
- Addison's patients by type, total (000s)
- Addison's patients by number of concomitant conditions, total (000s)
- Addison's patients with Autoimmune Thyroiditis (AT), total (000s)
- Addison's patients with T1D, total (000s)
- Addison's patients with Chronic Fatigue, total (000s)
- Addison's patients with Anaemia, total (000s)
- Addison's patients with Vitiligo, total (000s)
- Abbreviations and Acronyms used in the Report
- USA Prevalence of Addison's disease by 5-yr age cohort, males (000s)
- USA Prevalence of Addison's disease by 5-yr age cohort, females (000s)
- France Prevalence of Addison's disease by 5-yr age cohort, males (000s)
- France Prevalence of Addison's disease by 5-yr age cohort, females (000s)
- Germany Prevalence of Addison's disease by 5-yr age cohort, males (000s)
- Germany Prevalence of Addison's disease by 5-yr age cohort, females (000s)
- Italy Prevalence of Addison's disease by 5-yr age cohort, males (000s)
- Italy Prevalence of Addison's disease by 5-yr age cohort, females (000s)
- Spain Prevalence of Addison's disease by 5-yr age cohort, males (000s)
- Spain Prevalence of Addison's disease by 5-yr age cohort, females (000s)
- United Kingdom Prevalence of Addison's disease by 5-yr age cohort, males (000s)
- United Kingdom Prevalence of Addison's disease by 5-yr age cohort, females (000s)
- Brazil Prevalence of Addison's disease by 5-yr age cohort, males (000s)
- Brazil Prevalence of Addison's disease by 5-yr age cohort, females (000s)
- Japan Prevalence of Addison's disease by 5-yr age cohort, males (000s)
- Japan Prevalence of Addison's disease by 5-yr age cohort, females (000s)
- India Prevalence of Addison's disease by 5-yr age cohort, males (000s)
- India Prevalence of Addison's disease by 5-yr age cohort, females (000s)


View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...

Human Microbiome Market by Indication, Application, Product, Product Research, Technology Research - Global Forecast to 2025

Human Microbiome Market by Indication, Application, Product, Product Research, Technology Research - Global Forecast to 2025

  • $ 5650
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global human microbiome market is estimated to reach USD 899.1 million by 2025, growing at a CAGR of 21.1% during the forecast period (2022–2025) Factors such as increased focus on human microbiome ...

Ankylosing spondylitis (AS)- Market Insights, Epidemiology and Market Forecast-2023

Ankylosing spondylitis (AS)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Ankylosing spondylitis (AS) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.